This week, a study finds that a two-drug regimen of cabotegravir and rilpivirine works as maintenance therapy, according to 144-week results.
This Week in HIV Research: Kidney Function Improves With Protease Inhibitor Switch; and Viral Load Blips Predict Post-Treatment Control
This week, a study finds switching a protease inhibitor-based regimen from lopinavir or atazanavir to darunavir helps improve kidney function. Another study finds that viral load blips during early HIV treatment help predict post-treatment control....
This Week in HIV Research: Diabetes Rate Higher Among People With HIV; and 8-Week Hepatitis C Treatment for HIV/HCV Coinfection
This week, a study finds that people living with HIV are more likely to develop diabetes than the general population. Another study finds that 8 weeks of hepatitis C (HCV) treatment is highly effective in those with HIV/HCV coinfection.
Pretreatment CD4 count strongly predicted mortality in the first years of antiretroviral therapy, according to analysis of 18 cohorts in Europe and North America.
This Week in HIV Research: Long-Term Adherence Interventions Needed; and Preventing a Third of New HIV Infections
This week, a study finds that interventions to improve adherence often stop working over time and that long-term solutions are needed.
This Week in HIV Research: U.S. HIV Incidence Decreases; and Partner Services Most Effective Within 30 Days of Diagnosis
This week, a study estimates that the number of new HIV cases in the U.S. has steadily declined between 2003 and 2010, though the number of new cases remains around 40,000 a year.
This week, giving or receiving a viral load test using a special computer chip and a USB stick is possible, according to a proof-of-concept study.
This Week in HIV Research: Quitting Smoking Adds 5 Years to Life Expectancy, and Broadly Neutralizing Antibody Treatment Studied Further
This week, a study finds that quitting smoking could raise the life expectancy of people living with HIV by five years.
This week, a study examines how two precursor forms of vitamin D may help protect against HIV infection. Another study supports the idea of protease inhibitor monotherapy for some individuals living with HIV.
This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue
This week, another individual may have been cured of HIV after receiving a stem-cell transplant from a donor with a natural resistance to the virus.